series-c-plus
Stage
2
Investors
About
Kura Oncology discovers and develops targeted cancer therapies focused on precision medicines to improve outcomes for patients with cancers such as head and neck, lung, and acute leukemias.
Explore Kura Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.